Co-author: Colleen Brensinger
Co-authored publications (4):
- Lewis JD , Brensinger CM , Parlett LE , Hurtado-Lorenzo A , Kappelman MD . Provider specialization in inflammatory bowel diseases: quality of care and outcomes .Clin Gastroenterol Hepatol. 2024; 22 (12) : 2475-86.e14 . doi: 10.1016/j.cgh.2024.05.024 .
- Dawwas GK , Weiss A , Constant BD et al . Development and validation of claims-based definitions to identify incident and prevalent inflammatory bowel disease in administrative healthcare databases .Inflamm Bowel Dis. 2023; 29 (12) : 1993-6 . doi: 10.1093/ibd/izad053 .
- Lewis JD , Parlett LE , Jonsson Funk ML et al . Incidence, prevalence, and racial and ethnic distribution of inflammatory bowel disease in the United States .Gastroenterology. 2023; 165 (5) : 1197-1205.e2 . doi: 10.1053/j.gastro.2023.07.003 .
- Kappelman MD , Long MD , Zhang X et al . Comparing patient-reported outcomes among anti-TNF experienced patients with ulcerative colitis initiating vedolizumab versus tofacitinib .Crohns Colitis 360. 2023; 5 (3) : otad031 . doi: 10.1093/crocol/otad031 .